Bionomics has announced plans to meet with the US Food & Drug Administration (FDA) in Q2 2024 following the release of positive topline data from a Phase IIb trial of its lead candidate BNC210 to ...
Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to ...
The Florida Entomologist, Vol. 64, No. 4 (Dec., 1981), pp. 491-506 (16 pages) Aquatic stages of the mosquito Wyeomyia vanduzeei Dyar & Knab inhabit leaf axils of the epiphytic bromeliad Tillandsia ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果